Involvement of nitric oxide in phencyclidine-induced hyperlocomotion in mice

European Journal of Pharmacology

Volumn 286, Issue 3, 1995, Pages 291-297

  Noda, Yukihiro ^a   Yamada, Kiyofumi ^a   Furukawa, Hiroshi ^b   Nabeshima, Toshitaka ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MEIJO UNIVERSITY   (Japan)

Author keywords

(Mouse); Ataxia; Locomotion; Nitric oxide (NO) synthase inhibitor; Phencyclidine

Indexed keywords

7 NITROINDAZOLE; ARGININE; DEXTRO ARGININE; LYSINE; N(G) NITRO DEXTRO ARGININE METHYL ESTER; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PHENCYCLIDINE;

ANIMAL EXPERIMENT; ARTICLE; ATAXIA; BEHAVIOR; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENTIATION; HEAD MOVEMENT; HYPERACTIVITY; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; MOTOR COORDINATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SNIFFING; STEREOTYPY; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMAL; ARGININE; ATAXIA; LYSINE; MALE; MICE; MOTOR ACTIVITY; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; PHENCYCLIDINE; SUPPORT, NON-U.S. GOV'T;

EID: 0028824713     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(95)00464-X     Document Type: Article

References (55)

1. The dissociative anaesthetics, ketamine and phencyclidine, selective reduce excitation of central mammalian neurones by N-methyl-d-aspartate
2. Inhibition of nitric oxide synthase does not impair spatial learning
3. Inhibition of nitric oxide synthase does not prevent the induction of long-term potentiation in vivo
4. A comparison of PCP-like compounds for NMDA antagonism in two in vivo models
5. Altered synaptic plasticity and memory formation in nitric oxide synthase inhibitor-treated rats
6. Isolation of nitric oxide synthetase a calmodulin-requiring enzyme
7. Nitric oxide: an endogenous anticonvulsant substance
8. Endogenous nitric oxide modulates morphine-induced changes in locomotion and food intake in mice
9. Comparative study of normotensive and hypertensive nitric oxide synthase inhibitors on morphine withdrawal syndrome in rats
10. Interactions between glutamatergic and monoaminergic systems within the basal ganglia — implications for schizophrenia and Parkinson's disease
11. Effects of dopaminergic and cholinergic agents on phencyclidine-induced behaviors in rats
12. Acute and chronic phencyclidine effects on locomotor activity, stereotypy and ataxia in rats
13. Inhibition of nitric oxide synthesis impairs two different forms of learning
14. Second messenger role for NO widens to nervous and immune systems
15. Mechanisms of nitric oxide-induced neurotoxicity in primary brain cultures
16. Psychotropic drug influences on brain acetylcholine utilization
17. NMDA receptor activation in rat hippocampus induces cyclic GMP formation through the l-arginine nitric oxide pathway
18. Regional distribution of EDRF/NO-synthesizing enzymes in rat brain
19. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain
20. Potentiation of qunolinate-induced hippocampal lesions by inhibition of NO synthesis
21. G-monomethyl-l-arginine to l-citrulline and subsequently to l-arginine
22. Potentiation of phencyclidine-induced stereotyped behaviors in rats by thiorphan and bestatin
23. Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine
24. Inhibiting synthesis of the putative retrograde messenger nitric oxide results in amnesia in a passive avoidance task in the chick
25. Blockade of sensitization to the toxic effects of cocaine in mice by nitric oxide synthase inhibitors
26. Recent advances in the phencyclidine model of schizophrenia
27. Effects of risperidone on phencyclidine-induced behaviors: comparison with haloperidol and ritanserin
28. Formation of nitric oxide from l-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase
29. A simple and rapid method for assessing similarities among directly observable behavioral effects of drugs: PCP-like effects of 2-amino-5-phosphonovalerate in rats
30. Glutamate-dopamine receptor interaction in neuropsychiatric disorders
31. The NMDA receptor
32. Noncompetitive excitatory amino acid receptor antagonists
33. The N-methyl-d-aspartate receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats
34. Interaction between phencyclidine (PCP) and GABAergic drugs: clinical implications
35. Characterization of the novel nitric oxide synthase inhibitor 7-nitro indazole and related indazoles: antinociceptive and cardiovascular effects
36. Calcium-dependent GABA release from mouse brain slices following acute and chronic phencyclidine administration
37. Effects of lesions in the striatum, nucleus accumbens and medial raphe on phencyclidine-induced stereotyped behaviors and hyperactivity in rats
38. 1 receptor
39. Acute and chronic phencyclidine administration changes serotonin receptors in rat
40. Phencyclidine-induced head-weaving observed in mice after ritanserin treatment
41. Possible involvement of nitric oxide in quinolinic acid-induced convulsion in mice
42. Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger
43. Unique behavioral effects of the NMDA antagonist, CPP, upon injection into the medial pre-frontal cortex of rats
44. Vascular endothelial cells synthesize nitric oxide from l-arginine
45. L-NAME and MK-801 attenuate sensitization to the locomotor-stimulating effect of cocaine
46. Effects of ketamine and (+) cyclazocine on 4-aminopyridine and ‘magnesium free’ epileptogenic activity in hippocampal slices of rats
47. Intrastriatal injection of dl-2-amino-5-phosphonovaleric acid (AP-5) induces sniffing stereotypy that is antagonized by haloperidol and clozapine
48. Antagonism of AP-5- and amphetamine-induced behaviour by timelotem as compared with clozapine and haloperidol
49. A requirement for the intercellular messenger nitric oxide in long-term potentiation
50. 3H serotonin uptake in synaptosomal preparations from rat brain
51. Behavioural rating scales for assessing phencyclidine-induced locomotor activity, stereotyped behavior and ataxia in rats
52. MK-801-induced stereotypy and its antagonism by neuroleptic drugs
53. Variation in hydroxytryptamine metabolism in the rat: effects on the neurochemical response to phencyclidine
54. Interaction of phencyclidine with drugs affecting noradrenaline metabolism in the rat brain
55. Glutamate: a new target in schizophrenia?